These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29685010)

  • 1. Expressions and clinical significance of factors related to acute coronary syndrome.
    Sun H; Zhang J; Zheng Y; Shang S
    J Biol Regul Homeost Agents; 2018; 32(2):299-305. PubMed ID: 29685010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Analysis of Acute Coronary Syndrome with Serum IL-18, MMP-9, hs-CRP, and Plasma FIB.
    Yang Y; Li G; Zhang R
    Biomed Res Int; 2022; 2022():5984184. PubMed ID: 35028315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
    Li C; Zhang Z; Peng Y; Gao H; Wang Y; Zhao J; Pan C
    PLoS One; 2019; 14(8):e0220841. PubMed ID: 31387110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on Risk Stratification and the Prognostic Value of hs-TnT Combined with MMP-2 in Patients with Acute Coronary Syndrome.
    Li Y; Li L; Wang K; Wu P; Cui Y
    Biomed Res Int; 2021; 2021():1040171. PubMed ID: 34859099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome].
    Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of interleukin-33 and interleukin-6 in patients with acute coronary syndrome or stable angina.
    Liu CL; Shen DL; Zhu K; Tang JN; Hai QM; Zhang JY
    Clin Invest Med; 2013 Aug; 36(4):E234-41. PubMed ID: 23906495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
    Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation.
    Souza JR; Oliveira RT; Blotta MH; Coelho OR
    Arq Bras Cardiol; 2008 Feb; 90(2):86-90. PubMed ID: 18392379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma matrix metalloproteinases-2 and -9 levels are elevated in patients with acute coronary syndrome and coronary chronic total occlusion].
    Tang QD; Wu PS; Hou YQ; Huang Z; Zhou ZJ; Guo ZG; Xiu JC; Wang YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1004-7. PubMed ID: 19460733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.
    Tan J; Hua Q; Gao J; Fan ZX
    Clin Cardiol; 2008 Sep; 31(9):413-8. PubMed ID: 18781600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluated plasma interleukin-18/interleukin-10 ratio is a risk factor for acute coronary syndromes in patients with stable angina pectoris.
    Li Q; Li Z; Zhang X; Ruan Y; Qiu J
    Cardiol J; 2014; 21(1):83-8. PubMed ID: 23677727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome.
    Allal-Elasmi M; Zayani Y; Zidi W; Zaroui A; Feki M; Mourali S; Mechmeche R; Kaabachi N
    Clin Lab; 2014; 60(6):951-6. PubMed ID: 25016699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome.
    Darabi F; Aghaei M; Movahedian A; Pourmoghadas A; Sarrafzadegan N
    Mol Cell Biochem; 2016 Nov; 422(1-2):51-60. PubMed ID: 27590242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of C1q/TNF-related protein 1 and interleukin 6 in patients with acute coronary syndrome or stable angina pectoris.
    Tang JN; Shen DL; Liu CL; Wang XF; Zhang L; Xuan XX; Cui LL; Zhang JY
    Am J Med Sci; 2015 Feb; 349(2):130-6. PubMed ID: 25635749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.
    Ji Q; Zeng Q; Huang Y; Shi Y; Lin Y; Lu Z; Meng K; Wu B; Yu K; Chai M; Liu Y; Zhou Y
    Mediators Inflamm; 2014; 2014():165742. PubMed ID: 24733959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome.
    Wang XH; Liu SQ; Wang YL; Jin Y
    Genet Mol Res; 2014 Jun; 13(2):4260-6. PubMed ID: 25036169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ramipril on serum monocyte chemoattractant protein 1, interleukin-18, and interleukin-10 in elderly patients with acute coronary syndrome.
    Chen HQ; Tan HY; Yang YW; Qiu L; Liu XQ
    Heart Vessels; 2010 Mar; 25(2):77-81. PubMed ID: 20339966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 for the earliest stage acute coronary syndrome.
    Kobayashi N; Hata N; Kume N; Yokoyama S; Shinada T; Tomita K; Kitamura M; Shirakabe A; Inami T; Yamamoto M; Seino Y; Mizuno K
    Circ J; 2011; 75(12):2853-61. PubMed ID: 21963570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.